ARCHIVES

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000

French Legion d’Honneur Bestowed On Hortobagyi.

March 1, 2002

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

In Brief: Thomas Davis, Stanford Oncologist, Dead At 49; DeVita To Visit, NCI; Hunter Named WHI Liaison

September 4, 1992